A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 8, 2023

Primary Completion Date

December 30, 2023

Study Completion Date

April 15, 2024

Conditions
Atopic Dermatitis
Interventions
DRUG

BMX-010

Ointment

DRUG

Placebo

Ointment

Trial Locations (19)

29420

National Allergy and Asthma Research, LLC., North Charleston

33014

RM Medical Research, Miami Lakes

33134

Driven Research LLC, Coral Gables

33172

Lenus Research, Sweetwater

33486

Skin Care Research, Boca Raton

35244

Cahaba Dermatology & Skin Health Center, Birmingham

40241

Skin Sciences, Pllc, Louisville

47906

Physicians Research Group, West Lafayette

48084

Revival Research Institute, LLC, Troy

70448

Clinical Trials Management, LLC, Mandeville

72022

Dermatology Trial Associates, Bryant

72916

Johnson Dermatology, Fort Smith

77845

J&S Studies, Inc., College Station

78660

Austin Institute for Clinical Research, Pflugerville

80113

Colorado Skin Care, Englewood

84095

Jordan Valley Dermatology Center, South Jordan

90301

Axon Clinical Research, Inglewood

92024

California Dermatology & Clinical Research Institute, Encinitas

99202

Dermatology Specialists of Spokane (Dermatology Specialists of Spokane, PLLC), Spokane

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Innovaderm Research Inc.

OTHER

lead

BioMimetix JV, LLC

INDUSTRY